Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (IFF) (NYSE: IFF) generates a steady flow of news that reflects its role as a global leader in flavors, fragrances, food ingredients, health and biosciences. This news page aggregates company announcements, press releases and related coverage so readers can follow how IFF’s strategies, operations and governance evolve over time.
IFF’s news often highlights developments across its core segments—Taste, Health & Biosciences, Scent and Food Ingredients. Examples include updates on segment performance from quarterly earnings releases, commentary on market dynamics within these segments and information on productivity and margin initiatives. Investors and analysts can use these items to understand how the company’s segment-level trends contribute to overall performance.
Operational and technology-focused announcements are another key news category for IFF. Recent releases describe the implementation of the Colibri smart dosing robot at its Scent and Taste production plant in Chin Bee, Singapore, which is used to produce fragrance sample batches on demand, and the installation of a green hydrogen production facility at its Benicarló, Spain site to support sustainable fragrance ingredient manufacturing. News items also cover plans for new facilities, such as a scent creative center in Mumbai, India, designed to enhance fragrance innovation in that market.
Corporate governance, capital allocation and strategic partnerships feature prominently in IFF’s news flow. The company reports on board appointments, changes in committee assignments and amendments to its bylaws. It also announces dividends, share repurchase authorizations and collaborations, such as its strategic collaboration with BASF to develop next-generation enzyme technologies and biobased polymers. Bookmark this page to access a consolidated view of IFF’s latest publicly released information, from financial results to sustainability initiatives and board-level decisions.
Mativ Holdings (NYSE:MATV) appointed Deborah Borg to its Board of Directors, effective November 24, 2025. Borg will serve on Mativ’s Compensation Committee and Nominating & Governance Committee.
Borg is currently Executive Vice President and Chief People & Culture Officer at International Flavors & Fragrances (NYSE:IFF) and brings 25+ years of global leadership in compensation, benefits, succession planning, M&A and organizational change, with prior roles at General Motors, Dow Chemical and Bunge. Mativ leadership highlighted her experience guiding transformations and expected contributions to talent, strategy and culture as the company advances post‑merger objectives.
IFF (NYSE: IFF) installed a Colibri smart dosing robot at its Chin Bee production facility in Singapore on November 24, 2025, to speed fragrance sample production across Greater Asia. The system handles multiple ingredients simultaneously, runs four times faster than the previous setup and produces 200 sample batches in eight hours versus twenty-four hours before. The robot shortens formulation lead times from ideation to sample, increases automation and capacity, and complements IFF’s $30 million Singapore Innovation Center and other Colibri sites in Neuilly, France and Hilversum, Netherlands.
IFF (NYSE: IFF) opened a nature-based green hydrogen production facility at its Benicarló, Spain fragrance ingredients plant on November 6, 2025.
The site, in a 10-year renewable hydrogen agreement with Iberdrola, can produce 100 tons of green hydrogen annually, store it on-site with an integrated compressor, and supply hydrogenation for more than 50 key ingredients. IFF says the switch to green hydrogen will eliminate 2,000 tons of CO2e per year and supports its targets of -50% scope 1 & 2 and -30% scope 3 emissions by 2030 and net zero operations by 2040.
IFF (NYSE: IFF) announced that its Board of Directors declared a regular quarterly cash dividend of $0.40 per share. The dividend is payable on January 9, 2026 to shareholders of record as of December 19, 2025.
The announcement reiterates IFF's ongoing capital return via a regular quarterly dividend and provides contact points for media and investor relations.
IFF (NYSE: IFF) announced the 2025 IFF Science Awards honoring Dr. Carles Lerín and Prof. Jan Maarten van Dijl for contributions to human health, nutrition, microbiome science and antimicrobial research.
Dr. Lerín is recognized for research on childhood and adolescent obesity, maternal and early-life nutrition, microbiome links to metabolic health and betaine’s role in growth. Prof. van Dijl is recognized for advances in molecular bacteriology, microbial protein secretion and novel antimicrobial strategies. The award continues the Danisco Foundation legacy and includes a $35,000 prize, with candidates chosen via a rigorous IFF nomination process.
IFF (NYSE: IFF) appointed Brett Icahn and Richard Mulligan, Ph.D. to its board of directors, effective Oct. 20, 2025. The appointments follow a previously disclosed cooperation agreement with Icahn Capital LP. Icahn replaces Vincent Intrieri and was named to the Board’s Audit Committee and Transaction Committee. Mulligan replaces Margarita Paláu-Hernández and was named to the Board’s Innovation Committee. Management highlighted Icahn’s investment experience and Mulligan’s scientific track record. Intrieri and Paláu-Hernández stepped down on Oct. 20, 2025.
IFF (NYSE: IFF) announced a strategic collaboration with BASF on October 21, 2025 to accelerate IFF’s Designed Enzymatic Biomaterials™ platform and develop next‑generation enzyme and polymer technologies for fabric, dish, personal care and industrial cleaning applications.
The partnership combines IFF’s biotechnology and protein engineering with BASF’s chemical and sustainable‑product expertise to scale biobased polymers and innovative enzyme systems while both companies retain independent operations.
International Flavors & Fragrances (NYSE:IFF) will release Q3 2025 earnings after market close on Tue, Nov 4, 2025.
The company will host a live webcast on Wed, Nov 5, 2025 at 9:00 a.m. ET to review results and outlook; the webcast and slide presentation will be available at ir.iff.com. A recorded replay will be posted for those unable to join live.
Investor and media contacts are listed for follow-up.
NACD appointed Jesús Mantas and Wes Bricker to its board of directors, effective October 10, 2025. Mantas is recently retired as global leader of IBM Consulting Business Transformation Services and serves on the board of Biogen (Nasdaq: BIIB) where he chairs the compensation and management development committee. Bricker is Global Assurance Leader at PwC, a former SEC chief accountant, and leads PwC assurance teams across the network.
The appointments add expertise in digital transformation, innovation, assurance, governance, and capital markets to NACD as it advises corporate directors on evolving boardroom challenges.
FAQ
What is the current stock price of International Flavors&Fragranc (IFF)?
What is the market cap of International Flavors&Fragranc (IFF)?
